Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Clin Cancer Res. 2011 Mar 17;17(9):2874–2884. doi: 10.1158/1078-0432.CCR-10-2334

Figure 5. Comparative prognostic performance of eIF4E, mTOR, and eIF4E/4E-BP1, eIF4E/BP2 and eIF4E/PML mRNA.

Figure 5

(A–E) Kaplan Meier plots of distant metastasis events in a cohort of 621 node negative adjuvant naïve breast cancers dichotomized at the median of (A) eIF4E, (B) mTOR, (C) eIF4E/4E-BP2, (D) eIF4E/PML, and (E) eIF4E/4E-BP1 mRNA expression levels. Black: high, light grey: low